MX2008015058A - Formulaciones de sal de prednisolona. - Google Patents

Formulaciones de sal de prednisolona.

Info

Publication number
MX2008015058A
MX2008015058A MX2008015058A MX2008015058A MX2008015058A MX 2008015058 A MX2008015058 A MX 2008015058A MX 2008015058 A MX2008015058 A MX 2008015058A MX 2008015058 A MX2008015058 A MX 2008015058A MX 2008015058 A MX2008015058 A MX 2008015058A
Authority
MX
Mexico
Prior art keywords
tablets
prednisolone
salt formulations
odts
prednisolone salt
Prior art date
Application number
MX2008015058A
Other languages
English (en)
Inventor
Walid Habib
Kothari Bhareshkumar
Original Assignee
Cima Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/638,260 external-priority patent/US20070281014A1/en
Priority claimed from US11/638,216 external-priority patent/US8637076B2/en
Application filed by Cima Labs Inc filed Critical Cima Labs Inc
Publication of MX2008015058A publication Critical patent/MX2008015058A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a comprimidos que contienen sales de prednisolona, y en particular, fosfatos de sodio de prednisolona. Las formas de dosificación incluyen ODT y no ODT, comprimidos efervescentes y no efervescentes, y comprimidos que cumplan con ciertos criterios de funcionamiento.
MX2008015058A 2006-06-01 2007-05-31 Formulaciones de sal de prednisolona. MX2008015058A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81001506P 2006-06-01 2006-06-01
US11/638,260 US20070281014A1 (en) 2006-06-01 2006-12-13 Prednisolone salt formulations
US11/638,216 US8637076B2 (en) 2006-06-01 2006-12-13 Prednisolone salt formulations
PCT/US2007/012883 WO2007143061A2 (en) 2006-06-01 2007-05-31 Prednisolone salt formulations

Publications (1)

Publication Number Publication Date
MX2008015058A true MX2008015058A (es) 2009-04-14

Family

ID=38616310

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2008015059A MX2008015059A (es) 2006-06-01 2007-05-30 Formulaciones de sal prednisolona.
MX2008015058A MX2008015058A (es) 2006-06-01 2007-05-31 Formulaciones de sal de prednisolona.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2008015059A MX2008015059A (es) 2006-06-01 2007-05-30 Formulaciones de sal prednisolona.

Country Status (3)

Country Link
CA (2) CA2653485A1 (es)
MX (2) MX2008015059A (es)
WO (2) WO2007143131A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926722B1 (fr) * 2008-01-25 2010-09-03 Substipharm Dev Formulation pharmaceutique appropriee pour la preparation de comprimes orodispersibles de prednisolone

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE615854A (es) *
US3921636A (en) * 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
EP1133282A4 (en) * 1998-11-25 2006-03-29 Cima Labs Inc TASTE-MAKING DELIVERY SYSTEM WITH FAST RELEASE
WO2003053415A1 (en) * 2001-12-20 2003-07-03 Alpex Pharma Sa Pharmaceutical composition comprising skim milk powder
EP1589950A4 (en) * 2002-12-31 2010-07-28 Larry L Augsburger PROCESS FOR PREPARING PHARMACEUTICAL PHARMACEUTICAL FORMS COMPRISING ACTIVE COMPRESSION COMPONENTS
ZA200701576B (en) * 2004-04-30 2008-09-25 Astellas Pharma Inc Time-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition

Also Published As

Publication number Publication date
WO2007143131A9 (en) 2008-02-14
WO2007143131A2 (en) 2007-12-13
WO2007143131A3 (en) 2008-03-20
MX2008015059A (es) 2009-04-14
WO2007143061A2 (en) 2007-12-13
CA2653485A1 (en) 2007-12-13
CA2653480A1 (en) 2007-12-13
WO2007143061A3 (en) 2008-02-14

Similar Documents

Publication Publication Date Title
MY160456A (en) Benzodiazepine bromodomain inhibitor
EP2045251A4 (en) COMPOUNDS WHICH CAN INCLUDE THE UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC APPLICATIONS
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
TW200637522A (en) Skin treatment articles and methods
IL232447A0 (en) Formulations containing indoxacarb for topical administration to the skin
PL379212A1 (pl) Kompozycje bakteriobójcze, sposoby i układy
MX2007008790A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso.
MX349787B (es) Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido.
TW200740429A (en) Methods and dosage forms for reducing side effects of carbamate compounds
TW200700071A (en) Novel use
MX2007004955A (es) Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente.
TW200501965A (en) Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle
TW200630343A (en) 2-Alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
GB0502787D0 (en) Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use
ZA200900237B (en) Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
MX368363B (es) Forma de dosificacion efervescente.
MXPA05008902A (es) Soluciones de drogas en mentol.
TR200909786A1 (tr) Sefiksim içeren efervesan tablet ve granül formülasyonu.
MY150201A (en) Cosmetic composition for external adminstration in spray form
WO2007098924A3 (de) Zusammensetzung umfassend ein mittel zum stabilisieren von wirkstoffen im trinkwasser und eine brausemischung, verfahren zu deren herstellung und deren verwendung
GB0615105D0 (en) Novel compounds
MX2008015058A (es) Formulaciones de sal de prednisolona.
TW200633717A (en) Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents
MX2009005329A (es) Composiciones farmaceuticas anticonvulsivas.

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration